Several other equities analysts have also recently issued reports on XYL. Credit Suisse Group decreased their price target on shares of Xylem from $111.00 to $98.00 and set an “underperform” rating for the company in a research report on Friday, February 4th. Zacks Investment Research upgraded shares of Xylem from a “sell” rating to a “hold” rating and set a $89.00 price target for the company in a research report on Thursday, May 12th. TheStreet cut shares of Xylem from a “b” rating to a “c+” rating in a research report on Monday, February 7th. Stifel Nicolaus decreased their price target on shares of Xylem from $100.00 to $90.00 and set a “hold” rating for the company in a research report on Monday, April 18th. Finally, StockNews.com assumed coverage on shares of Xylem in a research note on Thursday, March 31st. They issued a “hold” rating on the stock. One analyst has rated the stock with a sell rating, nine have given a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $111.90.
XYL stock opened at $84.25 on Wednesday. The company has a quick ratio of 1.21, a current ratio of 1.62 and a debt-to-equity ratio of 0.59. Xylem has a 12 month low of $78.92 and a 12 month high of $138.78. The firm has a market cap of $15.17 billion, a P/E ratio of 36.31, a P/E/G ratio of 2.81 and a beta of 1.08. The company’s 50-day moving average price is $84.54 and its two-hundred day moving average price is $98.70.
In other news, SVP Colin R. Sabol sold 4,233 shares of the stock in a transaction dated Monday, April 18th. The shares were sold at an average price of $83.05, for a total value of $351,550.65. Following the completion of the sale, the senior vice president now owns 27,373 shares in the company, valued at $2,273,327.65. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.89% of the stock is currently owned by company insiders.
Hedge funds have recently made changes to their positions in the company. James Reed Financial Services Inc. purchased a new stake in Xylem during the fourth quarter worth about $26,000. Riverview Trust Co purchased a new stake in Xylem during the first quarter worth about $26,000. Cyrus J. Lawrence LLC purchased a new stake in Xylem during the first quarter worth about $26,000. AGF Investments LLC purchased a new stake in Xylem during the fourth quarter worth about $27,000. Finally, UMB Bank N A MO purchased a new stake in Xylem during the fourth quarter worth about $27,000. Institutional investors own 83.83% of the company’s stock.
Xylem Company Profile (Get Rating)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. It operates through three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions.
- Get a free copy of the StockNews.com research report on Xylem (XYL)
- 3 Outperforming Energy Stocks with More in the Tank
- American Well Corporation Stock May Well Be Bottoming
- There Are Cracks In The Paint At Sherwin-Williams
- Three Beaten Down Stocks The Insiders Are Buying
- Should Medtronic Make the Cut For Your Recovery Watchlist?
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.